Drs. Gudrun Rappold and Henning Frohlich Research Project

Drs. Gudrun Rappold and Henning Frohlich from Heidelberg University will discuss their research on the potential benefits of a PDE10A inhibitor for individuals with FOXP1 Syndrome.
February 1, 2025

Recording of past presentations and webinars are available on the Video page

Drs. Gudrun Rappold and Henning Frohlich from Heidelberg University will discuss their research on the potential benefits of a PDE10A inhibitor for individuals with FOXP1 Syndrome.

A recording may be available. Contact info@www.foxp1.org for access to the session recording or slides.

Keep Reading

Related Articles